Metropolis Healthcare Limited · NSE: METROPOLIS · BSE: 542650
Metropolis Healthcare
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 04 Aug 2026.
Q1 FY27 · Consolidated
Revenue
450.21₹ Cr
+16.6% vs year ago
Net profit
56.88₹ Cr
+25.7% vs year ago
EPS, basic
2.73₹
not comparable vs year ago
Net margin
12.6%
+0.9 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 450.21 | +16.6% | 56.88 | +25.7% | 2.73 | 04 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 424.68 | +23.0% | 50.96 | +74.3% | 2.46 | 13 May 2026 |
| Q3 FY26Oct–Dec 2025 | 405.91 | +25.8% | 42.09 | +33.7% | 7.99 | 04 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 429.19 | +22.7% | 52.89 | +13.3% | 10.17 | 04 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 386.06 | +23.2% | 45.25 | +18.7% | 8.70 | 07 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 345.29 | +4.3% | 29.23 | −20.0% | 5.69 | 13 May 2025 |
| Q3 FY25Oct–Dec 2024 | 322.77 | +10.9% | 31.47 | +15.3% | 6.11 | 04 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 349.79 | +13.4% | 46.70 | +31.0% | 9.08 | 08 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 313.36 | +13.1% | 38.11 | +31.5% | 7.41 | 13 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 331.00 | +17.1% | 36.53 | +9.1% | 7.11 | 23 May 2024 |
| Q3 FY24Oct–Dec 2023 | 291.12 | +2.0% | 27.29 | −23.9% | 5.30 | 05 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 308.50 | +2.7% | 35.66 | −11.9% | 6.92 | 07 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 277.09 | −1.0% | 28.98 | −13.7% | 5.62 | 03 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 282.55 | −7.6% | 33.49 | −16.6% | 6.50 | 18 May 2023 |
| Q3 FY23Oct–Dec 2022 | 285.46 | −2.6% | 35.86 | −13.0% | 6.99 | 11 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 300.35 | −0.8% | 40.48 | −30.7% | 7.88 | 09 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 279.86 | −14.4% | 33.56 | −55.2% | 6.53 | 12 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 305.90 | +4.9% | 40.15 | −34.5% | 7.81 | 25 May 2022 |
| Q3 FY22Oct–Dec 2021 | 293.05 | +6.7% | 41.22 | −29.7% | 8.02 | 12 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 302.62 | +4.9% | 58.40 | −3.5% | 11.39 | 11 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 326.76 | +128.3% | 74.92 | 26x | 14.65 | 07 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 291.73 | +41.0% | 61.32 | +295.8% | 12.05 | 28 May 2021 |
| Q3 FY21Oct–Dec 2020 | 274.78 | +23.3% | 58.64 | +39.6% | 11.50 | 11 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 288.35 | +29.1% | 60.52 | +40.3% | 11.88 | 12 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 143.13 | −29.6% | 2.88 | −89.3% | 0.57 | 12 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 206.97 | — | 15.49 | — | 3.09 | 30 May 2020 |
| Q3 FY20Oct–Dec 2019 | 222.85 | — | 42.01 | — | 8.38 | 08 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 223.28 | — | 43.13 | — | 8.57 | 18 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 203.30 | — | 26.91 | — | 5.34 | 08 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 0.00 | — | 0.00 | — | 0.00 | 16 May 2019 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 372.28 | +15.0% | 50.58 | +42.2% | 2.44 | 04 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 352.03 | +12.8% | 43.24 | +81.3% | 2.09 | 13 May 2026 |
| Q3 FY26Oct–Dec 2025 | 334.78 | +12.8% | 32.03 | +16.9% | 6.18 | 04 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 355.71 | +10.6% | 46.63 | +10.3% | 9.00 | 04 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 323.63 | +13.1% | 35.58 | +13.8% | 6.87 | 07 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 311.95 | +6.7% | 23.85 | −25.0% | 4.65 | 13 May 2025 |
| Q3 FY25Oct–Dec 2024 | 296.88 | +10.2% | 27.40 | +2.6% | 5.35 | 04 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 321.57 | +12.7% | 42.26 | +35.1% | 8.24 | 08 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 286.14 | +11.6% | 31.28 | +19.7% | 6.11 | 13 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 292.27 | +10.5% | 31.78 | −20.4% | 6.21 | 23 May 2024 |
| Q3 FY24Oct–Dec 2023 | 269.41 | +1.8% | 26.70 | −18.7% | 5.21 | 05 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 285.46 | +1.9% | 31.28 | −17.3% | 6.11 | 07 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 256.29 | −0.3% | 26.13 | −7.9% | 5.10 | 03 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 264.41 | +1.3% | 39.93 | +20.7% | 7.80 | 18 May 2023 |
| Q3 FY23Oct–Dec 2022 | 264.55 | +24.7% | 32.83 | +32.0% | 6.41 | 11 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 280.06 | +15.7% | 37.82 | −15.0% | 7.39 | 09 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 257.02 | −2.7% | 28.38 | −52.3% | 5.54 | 12 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 261.05 | +9.5% | 33.08 | −64.9% | 6.47 | 25 May 2022 |
| Q3 FY22Oct–Dec 2021 | 212.24 | −5.4% | 24.86 | −48.9% | 4.86 | 12 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 241.96 | −0.2% | 44.47 | −15.1% | 8.70 | 11 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 264.10 | +138.4% | 59.52 | 27x | 11.64 | 07 Aug 2021 |
| Q4 FY21Jan–Mar 2021 | 238.36 | +46.1% | 94.30 | +216.9% | 18.50 | 28 May 2021 |
| Q3 FY21Oct–Dec 2020 | 224.43 | +29.8% | 48.70 | +50.8% | 9.56 | 11 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 242.55 | +40.8% | 52.36 | +65.3% | 11.52 | 12 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 110.78 | −29.4% | 2.19 | −88.0% | 0.43 | 12 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 163.16 | — | 29.76 | — | 5.93 | 30 May 2020 |
| Q3 FY20Oct–Dec 2019 | 172.91 | — | 32.30 | — | 6.44 | 08 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 172.28 | — | 31.68 | — | 6.31 | 18 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 156.96 | — | 18.32 | — | 3.65 | 08 Aug 2019 |
| Q4 FY19Jan–Mar 2019 | 0.00 | — | 0.00 | — | 0.00 | 16 May 2019 |
60 filings on record for this company.